2.3
2022

Restrictions related to COVID-19 can negatively affect Russian patients with chronic spontaneous urticaria

Show more: Authors information and Publication history
Authors Information

1Central State Medical Academy of the Administrative Department of the President of Russia, Department of Dermatology and Cosmetology, Moscow, Russia
2Laboratory of Immune-Mediated Skin Diseases, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
3I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation4Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, I.M. Sechenov First Moscow

State Medical University (Sechenov University), Moscow, Russia
5Inflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, U.K.
6Research and Clinical Center for Neuropsychiatry, Moscow, Russia
7Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany
*The authors contributed equally to this work

History

Published: 20 July 2021
Accepted: 20 July 2021
Received: 15 April 2021

KEY WORDS
Chronic spontaneous urticaria; coronavirus; SARS-CoV-2; COVID-19; restrictions; telemedicine; digital medicine service; pandemic impact. 

Table of Content: Vol. 55 (No. 2) 2023 March

European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024